Home ProductsPharmaceutical Raw MaterialsPharmaceutical Raw Material Tranexamic Acid For Traumatic Bleeding
Certification
Good quality Boldenone Steroid for sales
Good quality Boldenone Steroid for sales
Thanks for your professionalism with works ,your quality is very well for us!

—— Lionk-South Africa

Wow,you sent goods so Quickly!I am glad to work with you!

—— Jack-USA

Products are received well. I hope business will boom soon,Lots of order will come youre way.

—— Richard-Holland

test E 250. very little pip. less than a previous source. love the cialis

—— Peter-USA

Just wanted to tell you that the product so far have been amazing. All seem to be very good quality and where easy to cook. Very pleased with it and.

—— Han-Holland

I'm Online Chat Now

Pharmaceutical Raw Material Tranexamic Acid For Traumatic Bleeding

China Pharmaceutical Raw Material Tranexamic Acid For Traumatic Bleeding supplier
Pharmaceutical Raw Material Tranexamic Acid For Traumatic Bleeding supplier Pharmaceutical Raw Material Tranexamic Acid For Traumatic Bleeding supplier

Large Image :  Pharmaceutical Raw Material Tranexamic Acid For Traumatic Bleeding

Product Details:

Payment & Shipping Terms:

Minimum Order Quantity: Negotiable
Price: Negotiable
Contact Now
Detailed Product Description

Product Description

Tranexamic Acid
CAS: 1197-18-8
Synonyms: Trans-4-Aminomethylcyclohexane-1-carboxylate; Trans-4-(Aminomethyl)cyclohexanecarboxylic acid; Amstat
EINECS No.: 212-818-4
M. F.: C8H15NO2
M. W.: 157.21
Assay: 99.0-101.0%
Apperance: White crystalline Powder
Type: Anesthetic Agents
Grade Standard: Cosmetic Grade, Medicine Grade
PH: 7.0~8.0
Chloride: 140ppm max
Loss on drying: 0.5%max
Sulfated ash: 0.1%max
Use: Hemostatic effect; (for pharmaceutical and cosmetic use)
Packing: 1kg Aluminum foil bag or 25kg fiber drum


Application:


Hemostatic, anti-allergic, anti-inflammatory effect
The development and fibrinolytic phenomena associated with the body heal under physiological or pathological state of fibrinolysis, increased vascular permeability, etc., but also on the body caused by reaction with fibrinolysis, a variety of symptoms and allergic reactions such as bleeding. This product can inhibit plasmin, and display bleeding, anti-allergic, anti-inflammatory effect.
The role of an anti-plasmin in Tranexamic acid can be combined with the plasmin and plasminogen and

fibrin affinity site lysine site (LBS) is strongly adsorbed by inhibition of plasmin, plasminogen and fibrin

binding and thus strongly inhibit fibrin by plasmin-induced decomposition; Addition, in the presence of

serum and other anti-plasmin macroglobulin, tranexamic acid antifibrinolytic effect is more obvious.

 

Specification:

 

Items Tested Specification BP2007 Result
Characteristics White or almost white, crystalline powder White crystalline powder
Melting point More than 300 degree Conforms
Identification Infrared absorption atlas consistent with the contrast atlas Conforms
Solubility Soluble in water, practically insoluble in acetone and alcohol Conforms
Clarity and color Solution should clarify and colorless Conforms
PH value 7.0_8.0 7.3
Related substances
Liquid chromatography
Impurity A: not more than 0.1%
Impurity B: not more than 0.2%
Impurity C: not more than 0.1%
Impurity D: not more than 0.1%
0
0.10%
0.01%
0.01%
Loss on drying Not more than 0.5% 0.20%
Sulphate Not more than 0. 07% 0.01%
Chloride Not more than 140ppm Less than 140ppm
Heavy Metals Not more than 10ppm Less than 10ppm
Residue on Ignition Not more than 0.1% 0.02%
Assay (HPLC) ≥99.0% 99.68%
Conclusion Conforms USP34

 

Function of Aminomethylbenzoic Acid:

A- For fibrinolytic hemorrhages, such as brain, lung, uterine, the prostate gland, adrenal gland, thyroid gland, trauma or surgical bleeding.

B- Intraoperative early medication or preoperative medication, can reduce bleeding in the operation, and decrease the amount of blood transfusion.

C- Also used in pulmonary hemorrhage, liver cirrhosis hemorrhage and upper gastrointestinal hemorrhage.

D- Used in bleeding caused by fibrinolysis process hyperfunction:
Such as abnormal bleeding of operation for the lung, liver, pancreas, prostate, thyroid, adrenal surgery.
Such as obstetrics and postpartum hemorrhage and tuberculosis hemoptysis or blood-stained sputum, hematuria, prostatic hypertrophy bleeding, upper gastrointestinal bleeding, etc.

E- Can also be used for bleeding caused by excessive streptokinase or urokinase.

Usage:


1. Hemostatic, significant effect on traumatic bleeding, preoperative prophylactic medication can decrease operation hemorrhage.
2. The chemical structure of tranexamic acid and lysine, competitive inhibition of plasminogen to fibrin adsorption, to prevent their activation, protect the fiber protein was not degraded by the enzyme and dissolved, ultimately achieve hemostasis effect.
3. All applicable in the treatment of acute or chronic, localized or systemic primary fibrinolysis hyperfunction caused by bleeding, such as obstetric hemorrhage, renal hemorrhage, hypertrophy of the prostate, hemophilia hemorrhage, pulmonary tuberculosis hemoptysis, bleeding in the stomach, liver, lung, spleen and other organs of hemorrhage after operation
4. The clinical effect of tranexamic acid on insect bites, eczema and dermatitis, simple purpura, chronic urticaria, artificial sex urticaria, rash and drug poisoning effect, also have certain effects on erythroderma, scleroderma, SLE, erythema multiforme, herpes zoster and alopecia areata, curative effect of hereditary angioedema is also good.

Contact Details
Wuhan Yuancheng Technology Development Co., Ltd.

Contact Person: Ron

Send your inquiry directly to us (0 / 3000)